The rise of antibiotic resistance, largely due to overuse and misuse, has become a significant global health concern. Consequently, the need for prudent prescribing, particularly of antibiotics, is more critical than ever. This article aims to provide a comprehensive guide to the rational use of antibiotics in clinical practice.
Antibiotic resistance occurs when bacteria change in response to the use of these medicines. It is a natural phenomenon but is exacerbated by the misuse of antibiotics. Resistant bacteria survive and multiply, causing more harm. Prudent prescribing is a key strategy to combat this problem.
Rational use of antibiotics involves prescribing the right antibiotic, at the right dose, for the right duration, and for the right indication. It requires a thorough understanding of the pharmacokinetics and pharmacodynamics of antibiotics, as well as the local epidemiology of infectious diseases and resistance patterns.
One strategy is to use narrow-spectrum antibiotics whenever possible. Broad-spectrum antibiotics should be reserved for severe or life-threatening infections. Another strategy is to de-escalate antibiotic therapy based on culture results, switching from broad-spectrum to narrow-spectrum antibiotics whenever feasible. Regular review of antibiotic prescriptions is also crucial.
Antimicrobial stewardship programs (ASPs) are key to promoting prudent prescribing. ASPs involve coordinated interventions designed to improve and measure the appropriate use of antimicrobials. They not only optimize clinical outcomes but also minimize unintended consequences of antimicrobial use, including resistance.
Prudent prescribing of antibiotics is an essential part of good clinical practice. It helps to prevent antibiotic resistance and ensures the continued effectiveness of these life-saving drugs. By understanding and implementing strategies for rational antibiotic use, healthcare professionals can play a crucial role in tackling the global health challenge of antibiotic resistance.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation